Abstract
Multiple comparison procedures play an important role in controlling the accuracy of clinical trial results while trial eligibility and exclusions have the potential to introduce bias and reduce external validity. This chapter introduces the issues and sources of multiplicity and provides a description of the many different procedures that can be used to address multiplicity primarily used in the confirmatory clinical trial setting. Additionally, trial inclusion/exclusion criteria and enrichment strategies are reviewed.
This is a preview of subscription content, log in via an institution to check access.
References
Dmitrienko A, D’Agostino R (2013) Traditional multiplicity adjustment methods in clinical trials. Stat Med 32(29):5172–5218. https://doi.org/10.1002/sim.5990
Dmitrienko A, D’Agostino RB (2018) Multiplicity considerations in clinical trials. N Engl J Med 378(22):2115–2122. https://doi.org/10.1056/NEJMra1709701
Dmitrienko A, D’Agostino RB Sr, Huque MF (2013) Key multiplicity issues in clinical drug development. Stat Med 32(7):1079–1111. https://doi.org/10.1002/sim.5642
Dunn OJ (1961) Multiple comparisons among means. J Am Stat Assoc 56(293):52–64. https://doi.org/10.1080/01621459.1961.10482090
Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50(272):1096–1121. https://doi.org/10.1080/01621459.1955.10501294
EMA (European MedicinesAgency) (2017) Guideline on multiplicity issues in clinical trials. Retrieved from www.ema.europa.eu/contact
FDA (U.S. Food and Drug Administration) (2017) Multiple endpoints in clinical trials: guidance for industry. Retrieved from http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm
Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, … Loder E (2017) Guidelines for the content of statistical analysis plans in clinical trials. JAMA 318(23): 2337. https://doi.org/10.1001/jama.2017.18556
Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, Lücke C, Woitek F, … Linke A (2016). Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis. JAMA 316(6): 592. https://doi.org/10.1001/jama.2016.10302
Hochberg Y (1988) A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75(4):800–802. https://doi.org/10.1093/biomet/75.4.800
Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6(2):65–70. Retrieved from https://www.jstor.org/stable/pdf/4615733.pdf?refreqid=excelsior%3Ab73e56d22a17fe5eebc22397ada28121
Hommel G (1988) A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika 75(2):383–386. https://doi.org/10.1093/biomet/75.2.383
Mehrotra DV, Heyse JF (2004) Use of the false discovery rate for evaluating clinical safety data. Stat Methods Med Res 13(3):227–238. https://doi.org/10.1191/0962280204sm363ra
Meltzer HY, Cucchiaro J, Silva R, Ogasa M, Phillips D, Xu J, … Loebel A (2011) Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. Am J Psychiatry 168(9): 957–967. https://doi.org/10.1176/appi.ajp.2011.10060907
Proschan MA, Waclawiw MA (2000) Practical guidelines for multiplicity adjustment in clinical trials. Control Clin Trials 21(6):527–539. https://doi.org/10.1016/S0197-2456(00)00106-9
Rothwell PM (2005) External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 365(9453):82–93. https://doi.org/10.1016/S0140-6736(04)17670-8
Šidák Z (1967) Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 62(318):626–633. https://doi.org/10.1080/01621459.1967.10482935
Simes RJ (1986) An improved Bonferroni procedure for multiple tests of significance. Biometrika 73(3):751–754. https://doi.org/10.1093/biomet/73.3.751
Wiens BL (2003) A fixed sequence Bonferroni procedure for testing multiple endpoints. Pharm Stat 2(3):211–215. https://doi.org/10.1002/pst.064
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Salter, A., Miller, J.P. (2020). Controlling for Multiplicity, Eligibility, and Exclusions. In: Piantadosi, S., Meinert, C. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_210-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52677-5_210-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52677-5
Online ISBN: 978-3-319-52677-5
eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering